Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sean M Devlin

Showing results (71-80 of 173) with videos related to

Pageof 18
Sort By:
Leukemia & Lymphoma|September 17, 2014
Incidence, nature and mortality of cytomegalovirus infection after double-unit cord blood transplantParastoo B Dahi, Miguel A Perales, Sean M Devlin, et al.
Blood Advances|November 10, 2022
Low toxicity and excellent outcomes in patients with DLBCL without residual lymphoma at the time of CD19 CAR T-cell therapyKitsada Wudhikarn, Ana Alarcon Tomas, Jessica R Flynn, et al.
Leukemia & Lymphoma|September 10, 2023
Utility of routine pulmonary function test after autologous hematopoietic cell transplantation in lymphomaParastoo B Dahi, Sheila Kenny, Jessica Flynn, et al.
Transplantation and Cellular Therapy|May 11, 2022
Evaluation of Melphalan Exposure in Lymphoma Patients Undergoing BEAM and Autologous Hematopoietic Cell TransplantationParastoo B Dahi, Andrew Lin, Michael Scordo, et al.
Blood Advances|March 29, 2019
Racial disparities in access to HLA-matched unrelated donor transplants: a prospective 1312-patient analysisJuliet N Barker, Kirsten Boughan, Parastoo B Dahi, et al.
Bone Marrow Transplantation|October 25, 2019
Favorable long-term outcomes of hematopoietic stem cell transplantation for CMML with myeloablative conditioning, anti-thymocyte globulin, and CD34<sup>+</sup> selected graftRichard J Lin, Matias Sanchez, Kamal Abbi, et al.
Leukemia & Lymphoma|January 9, 2018
Predictive biomarkers and practical considerations in the management of carfilzomib-associated cardiotoxicityNikoletta Lendvai, Ioanna Tsakos, Sean M Devlin, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 31, 2017
Revaccination after Autologous Hematopoietic Stem Cell Transplantation Is Safe and Effective in Patients with Multiple Myeloma Receiving Lenalidomide MaintenanceMeighan Palazzo, Gunjan L Shah, Olivia Copelan, et al.
Blood|February 2, 2018
A phase 1 study of ibrutinib in combination with R-ICE in patients with relapsed or primary refractory DLBCLCraig S Sauter, Matthew J Matasar, Heiko Schoder, et al.
Blood|September 27, 2012
Recombinant human interleukin-7 (CYT107) promotes T-cell recovery after allogeneic stem cell transplantationMiguel-Angel Perales, Jenna D Goldberg, Jianda Yuan, et al.
Pageof 18

Showing results (71-80 of 173) with videos related to

Sort By:
Pageof 18
Leukemia & Lymphoma|September 17, 2014
Incidence, nature and mortality of cytomegalovirus infection after double-unit cord blood transplantParastoo B Dahi, Miguel A Perales, Sean M Devlin, et al.
Blood Advances|November 10, 2022
Low toxicity and excellent outcomes in patients with DLBCL without residual lymphoma at the time of CD19 CAR T-cell therapyKitsada Wudhikarn, Ana Alarcon Tomas, Jessica R Flynn, et al.
Leukemia & Lymphoma|September 10, 2023
Utility of routine pulmonary function test after autologous hematopoietic cell transplantation in lymphomaParastoo B Dahi, Sheila Kenny, Jessica Flynn, et al.
Transplantation and Cellular Therapy|May 11, 2022
Evaluation of Melphalan Exposure in Lymphoma Patients Undergoing BEAM and Autologous Hematopoietic Cell TransplantationParastoo B Dahi, Andrew Lin, Michael Scordo, et al.
Blood Advances|March 29, 2019
Racial disparities in access to HLA-matched unrelated donor transplants: a prospective 1312-patient analysisJuliet N Barker, Kirsten Boughan, Parastoo B Dahi, et al.
Bone Marrow Transplantation|October 25, 2019
Favorable long-term outcomes of hematopoietic stem cell transplantation for CMML with myeloablative conditioning, anti-thymocyte globulin, and CD34<sup>+</sup> selected graftRichard J Lin, Matias Sanchez, Kamal Abbi, et al.
Leukemia & Lymphoma|January 9, 2018
Predictive biomarkers and practical considerations in the management of carfilzomib-associated cardiotoxicityNikoletta Lendvai, Ioanna Tsakos, Sean M Devlin, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 31, 2017
Revaccination after Autologous Hematopoietic Stem Cell Transplantation Is Safe and Effective in Patients with Multiple Myeloma Receiving Lenalidomide MaintenanceMeighan Palazzo, Gunjan L Shah, Olivia Copelan, et al.
Blood|February 2, 2018
A phase 1 study of ibrutinib in combination with R-ICE in patients with relapsed or primary refractory DLBCLCraig S Sauter, Matthew J Matasar, Heiko Schoder, et al.
Blood|September 27, 2012
Recombinant human interleukin-7 (CYT107) promotes T-cell recovery after allogeneic stem cell transplantationMiguel-Angel Perales, Jenna D Goldberg, Jianda Yuan, et al.
Pageof 18